Articles related to Adolescent Medicine

Past-year creatine use among U.S. adolescents roughly doubled between 2019 and 2024, even as anabolic steroid use continued a two-decade decline, according to a national survey of nearly 875,000 students.

A resurgent social media challenge involving high-dose diphenhydramine ingestion has been linked to seizures, cardiac arrest, and adolescent deaths, with poison center calls more than doubling in the first half of 2026 compared with all of 2025.

A 14-year-old athlete presenting with exertional dyspnea and partial albuterol response prompted a structured biopsychosocial workup that revealed anxiety disorder rather than exercise-induced asthma as the primary driver.

The FDA cleared the Dexcom Stelo Glucose Biosensor System for over-the-counter use in children ages 2 and older who do not use insulin, expanding a device previously limited to adults and supporting caregiver-supervised home glucose monitoring.

The GINA 2026 update introduces age-stratified primary care flowcharts for asthma exacerbation management, expands biologic guidance including depemokimab, and adds a formal red-flag list for fatal or near-fatal asthma risk in adults and adolescents.

A JCEM clinical guidance article outlines a two-criterion diagnostic standard for adolescent PCOS, requiring both persistent hyperandrogenism and menstrual irregularity, and frames adolescence as the critical window for metabolic and psychosocial risk stratification.